Seoulin Bioscience Co.,Ltd. (KOSDAQ: 038070)
South Korea
· Delayed Price · Currency is KRW 6,210.00
-10.00 (-0.16%)
Nov 15, 2024, 9:00 AM KST
Seoulin Bioscience Co.,Ltd. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 84,514 | 89,569 | 104,708 | 80,539 | 65,085 | 54,410 | Upgrade
|
| Revenue Growth (YoY) | -2.34% | -14.46% | 30.01% | 23.74% | 19.62% | 9.09% | Upgrade
|
| Cost of Revenue | 65,827 | 69,699 | 80,417 | 59,469 | 48,569 | 40,609 | Upgrade
|
| Gross Profit | 18,687 | 19,871 | 24,292 | 21,070 | 16,516 | 13,801 | Upgrade
|
| Selling, General & Admin | 14,469 | 15,016 | 12,475 | 11,144 | 9,626 | 9,662 | Upgrade
|
| Research & Development | 817.96 | 785.23 | 870.46 | 786.82 | 998.37 | 954.53 | Upgrade
|
| Other Operating Expenses | 458.82 | 441.22 | 396.47 | 382.27 | 335.09 | 321.83 | Upgrade
|
| Operating Expenses | 17,281 | 17,376 | 15,094 | 13,619 | 12,046 | 11,998 | Upgrade
|
| Operating Income | 1,405 | 2,495 | 9,198 | 7,451 | 4,471 | 1,803 | Upgrade
|
| Interest Expense | -1,461 | -2,482 | -2,287 | -224.55 | -18.66 | -16.45 | Upgrade
|
| Interest & Investment Income | 1,409 | 2,051 | 1,637 | 303.78 | 253.7 | 255.12 | Upgrade
|
| Earnings From Equity Investments | 54.99 | 85.1 | 121.01 | 114.5 | 89.12 | 50.15 | Upgrade
|
| Currency Exchange Gain (Loss) | 60.98 | -308.95 | -63.7 | -178.86 | 144.62 | 237.27 | Upgrade
|
| Other Non Operating Income (Expenses) | 3,730 | 3,441 | 3,808 | -397.15 | 724.33 | 566.3 | Upgrade
|
| EBT Excluding Unusual Items | 5,199 | 5,280 | 12,413 | 7,069 | 5,664 | 2,895 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -639.53 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4,920 | -4,966 | 2,011 | 160.11 | 118.2 | 8,765 | Upgrade
|
| Gain (Loss) on Sale of Assets | -39.3 | -31.42 | -1.06 | 14,153 | 0.27 | -0 | Upgrade
|
| Asset Writedown | - | - | -393.03 | -1,044 | - | -361 | Upgrade
|
| Other Unusual Items | -2,665 | -2,211 | - | - | - | - | Upgrade
|
| Pretax Income | -2,425 | -1,929 | 14,029 | 20,338 | 5,782 | 10,659 | Upgrade
|
| Income Tax Expense | 472.13 | 394.29 | 3,464 | 4,459 | 981.4 | 1,772 | Upgrade
|
| Earnings From Continuing Operations | -2,897 | -2,323 | 10,565 | 15,879 | 4,801 | 8,887 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 29.47 | -111.04 | - | - | Upgrade
|
| Net Income to Company | -2,897 | -2,323 | 10,595 | 15,768 | 4,801 | 8,887 | Upgrade
|
| Minority Interest in Earnings | 2,306 | 2,206 | -435.72 | -178.88 | 91.64 | -3.21 | Upgrade
|
| Net Income | -590.62 | -117.55 | 10,159 | 15,589 | 4,893 | 8,884 | Upgrade
|
| Net Income to Common | -590.62 | -117.55 | 10,159 | 15,589 | 4,893 | 8,884 | Upgrade
|
| Net Income Growth | - | - | -34.84% | 218.64% | -44.93% | 238.45% | Upgrade
|
| Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 9 | 11 | 9 | 9 | 9 | Upgrade
|
| Shares Change (YoY) | -10.76% | -19.42% | 23.72% | -0.07% | -1.26% | -0.72% | Upgrade
|
| EPS (Basic) | -69.00 | -13.73 | 1185.54 | 1815.28 | 569.32 | 1023.53 | Upgrade
|
| EPS (Diluted) | -69.00 | -13.73 | 817.07 | 1815.11 | 569.17 | 1020.42 | Upgrade
|
| EPS Growth | - | - | -54.98% | 218.90% | -44.22% | 240.51% | Upgrade
|
| Free Cash Flow | 4,271 | -14.95 | -4,817 | 7,984 | 3,283 | 7,052 | Upgrade
|
| Free Cash Flow Per Share | 498.95 | -1.75 | -453.40 | 929.72 | 382.04 | 810.25 | Upgrade
|
| Dividend Per Share | 97.664 | 97.664 | - | - | - | - | Upgrade
|
| Gross Margin | 22.11% | 22.18% | 23.20% | 26.16% | 25.38% | 25.37% | Upgrade
|
| Operating Margin | 1.66% | 2.78% | 8.78% | 9.25% | 6.87% | 3.31% | Upgrade
|
| Profit Margin | -0.70% | -0.13% | 9.70% | 19.36% | 7.52% | 16.33% | Upgrade
|
| Free Cash Flow Margin | 5.05% | -0.02% | -4.60% | 9.91% | 5.04% | 12.96% | Upgrade
|
| EBITDA | 2,783 | 3,781 | 10,215 | 9,381 | 6,455 | 3,456 | Upgrade
|
| EBITDA Margin | 3.29% | 4.22% | 9.76% | 11.65% | 9.92% | 6.35% | Upgrade
|
| D&A For EBITDA | 1,378 | 1,287 | 1,017 | 1,930 | 1,984 | 1,653 | Upgrade
|
| EBIT | 1,405 | 2,495 | 9,198 | 7,451 | 4,471 | 1,803 | Upgrade
|
| EBIT Margin | 1.66% | 2.78% | 8.78% | 9.25% | 6.87% | 3.31% | Upgrade
|
| Effective Tax Rate | - | - | 24.69% | 21.92% | 16.97% | 16.62% | Upgrade
|
| Advertising Expenses | - | 227.45 | 119.05 | 141.61 | 183.42 | 292.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.